HIGHLIGHTS
- who: Younes Belkouchi et al. from the University of Milano-Bicocca, Italy have published the research: Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume, in the Journal: (JOURNAL)
- what: The aim was to evaluate the biomarkers based on Overall survival (OS) and Progression-free survival (PFS). The authors chose to compare an increase or decrease Two parameters were found to be significant: Third, since one of the key aim of this study was to compare the ability of RECIST and Volume to predict PFS/OS, the authors wanted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.